The Biomedical Division of PHC Corporation, based in Japan, will present a prototype of its new cell expansion syst...
Japan’s biotech sector is a landscape rife with opportunity, yet also a complex market that requires a deep unders...
Japan has a robust drug discovery capability, having developed an interleukin-6 inhibitor, a programmed cell death prote...
Japan's biotech ecosystem is at a pivotal moment, characterised by both challenges and opportunities. Despite a rich his...
On July 30 2024, Japanese Prime Minister Fumio Kishida unveiled a roadmap to establish Japan as a ‘drug discovery ...
Kaneka Corporation has opened its Tomatoh Manufacturing Site in the Tomakomai Tobu Area of Hokkaido, Japan for the purpo...
Japanese firm Hitachi High-Tech Corporation and Korea-based Gencurix, Inc. have entered a strategic partnership in the f...
Japan-based Olympus Corporation, a global medical technology company, has announced the launch of two new jaw designs in...
Japan-based Hitachi High-Tech Corporation has announced the global launch of TM4000PlusIII and TM4000III Tabletop Micros...
Like in the previous edition, MEDICAL JAPAN TOKYO features six sub shows. First off is the HOSPITAL EXPO, which i...
Aevice Health, a leading provider of remote monitoring solutions for chronic respiratory disease management, has raised ...
Japan-based pharma firm Daiichi Sankyo and global life sciences company Merck, known as MSD outside of the United States...
Japan-based Terumo Corporation has established Terumo Ventures, a Corporate Venture Capital (CVC) organisation responsib...
Japan-based Otsuka Pharmaceutical Co. and Jnana Therapeutics Inc. have entered into a definitive merger agreement ...
Kyowa Kirin Asia Pacific, a wholly owned subsidiary of Japan-based Kyowa Kirin Co., has announced plans to transform its...
Biogen Inc., Beckman Coulter, Inc. (both based in the US) and Japan-based Fujirebio have announced a collaboration to po...
AstraZeneca K.K. and United Immunity have signed an agreement for joint research on next-generation lipid nanoparticles ...
Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with Gene Th...
